# Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

> **NCT04061824** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 150 (actual)

## Conditions studied

- Hypertension
- Dyslipidemias

## Interventions

- **DRUG:** Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination))
- **DRUG:** Two separated drugs(ARB(Angiotensin Ⅱ receptor blocker) and statin)

## Key facts

- **NCT ID:** NCT04061824
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-24
- **Primary completion:** 2018-12-20
- **Final completion:** 2018-12-20
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04061824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04061824, "Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04061824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*